Toxicology Laboratory Industry Analysis in North America
Toxicology Laboratory Industry Analysis in North America by Alcohol, Amphetamines, Barbiturates, Benzodiazepines, Opiates/Opioids, Tricyclic Antidepressants, and Z Drugs from 2024 to 2034
Analysis of Toxicology Laboratory Industry Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Table of Content
1. Executive Summary 1.1. North America Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Country Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. North America Industry Analysis 2019-2023 and Forecast, 2024-2034 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019-2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024-2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. North America Industry Analysis 2019-2023 and Forecast 2024-2034, By Drug Class 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Drug Class, 2019-2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Drug Class, 2024-2034 5.3.1. Amphetamines 5.3.2. Alcohol 5.3.3. Barbiturates 5.3.4. Benzodiazepines 5.3.5. Illicit Drugs 5.3.6. Opiates/Opioids 5.3.7. Tricyclic’s Antidepressants 5.3.8. Z Drugs 5.4. Y-o-Y Growth Trend Analysis By Drug Class, 2019-2023 5.5. Absolute $ Opportunity Analysis By Drug Class, 2024-2034 6. North America Industry Analysis 2019-2023 and Forecast 2024-2034, By Product 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2019-2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2024-2034 6.3.1. Reagent and Kits 6.3.1.1. ELISA 6.3.1.2. PCR 6.3.1.3. Enzyme Multiplied Immunoassay Technique (EMIT) 6.3.1.4. Radio Immuno-sorbent Assay (RIA) 6.3.2. Instruments 6.3.2.1. Immunochemistry Analyzers 6.3.2.2. PCR Machine 6.3.2.3. Gas Chromatography/Mass Spectrometry (GS/MS) 6.3.2.4. High Performance Liquid Chromatography(HPLC) 6.4. Y-o-Y Growth Trend Analysis By Product, 2019-2023 6.5. Absolute $ Opportunity Analysis By Product, 2024-2034 7. North America Industry Analysis 2019-2023 and Forecast 2024-2034, By Sample 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Sample, 2019-2023 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Sample, 2024-2034 7.3.1. Urine 7.3.2. Blood 7.3.3. Hair 7.3.4. Oral Fluid 7.4. Y-o-Y Growth Trend Analysis By Sample, 2019-2023 7.5. Absolute $ Opportunity Analysis By Sample, 2024-2034 8. North America Industry Analysis 2019-2023 and Forecast 2024-2034, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2019-2023 8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2024-2034 8.3.1. Hospitals 8.3.2. Clinics 8.3.3. Diagnostic Laboratories 8.3.4. Forensic Laboratories 8.3.5. Rehabilitation Centres 8.4. Y-o-Y Growth Trend Analysis By End User, 2019-2023 8.5. Absolute $ Opportunity Analysis By End User, 2024-2034 9. North America Industry Analysis 2019-2023 and Forecast 2024-2034, By Country 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Country, 2019-2023 9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Country 2024-2034 9.3.1. U.S. 9.3.2. Canada 9.4. Market Attractiveness Analysis By Country 10. U.S. Industry Analysis 2019-2023 and Forecast 2024-2034, By Region 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024-2034 10.2.1. By Region 10.2.2. By Drug Class 10.2.3. By Product 10.2.4. By Sample 10.2.5. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Region 10.3.2. By Drug Class 10.3.3. By Product 10.3.4. By Sample 10.3.5. By End User 10.4. Key Takeaways 11. Canada Industry Analysis 2019-2023 and Forecast 2024-2034, By Region 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024-2034 11.2.1. By Region 11.2.2. By Drug Class 11.2.3. By Product 11.2.4. By Sample 11.2.5. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Region 11.3.2. By Drug Class 11.3.3. By Product 11.3.4. By Sample 11.3.5. By End User 11.4. Key Takeaways 12. Market Structure Analysis 12.1. Competition Dashboard 12.2. Competition Benchmarking 12.3. Market Share Analysis of Top Players 12.3.1. By Country 12.3.2. By Drug Class 12.3.3. By Product 12.3.4. By Sample 12.3.5. By End User 13. Competition Analysis 13.1. Competition Deep Dive 13.1.1. Thermo Fisher Scientific, Inc 13.1.1.1. Overview 13.1.1.2. Product Portfolio 13.1.1.3. Profitability by Market Segments 13.1.1.4. Sales Footprint 13.1.1.5. Strategy Overview 13.1.1.5.1. Marketing Strategy 13.1.1.5.2. Product Strategy 13.1.1.5.3. Channel Strategy 13.1.2. Danaher Corporation 13.1.2.1. Overview 13.1.2.2. Product Portfolio 13.1.2.3. Profitability by Market Segments 13.1.2.4. Sales Footprint 13.1.2.5. Strategy Overview 13.1.2.5.1. Marketing Strategy 13.1.2.5.2. Product Strategy 13.1.2.5.3. Channel Strategy 13.1.3. Agilent Technologies 13.1.3.1. Overview 13.1.3.2. Product Portfolio 13.1.3.3. Profitability by Market Segments 13.1.3.4. Sales Footprint 13.1.3.5. Strategy Overview 13.1.3.5.1. Marketing Strategy 13.1.3.5.2. Product Strategy 13.1.3.5.3. Channel Strategy 13.1.4. Alere, Inc. 13.1.4.1. Overview 13.1.4.2. Product Portfolio 13.1.4.3. Profitability by Market Segments 13.1.4.4. Sales Footprint 13.1.4.5. Strategy Overview 13.1.4.5.1. Marketing Strategy 13.1.4.5.2. Product Strategy 13.1.4.5.3. Channel Strategy 13.1.5. Bio Rad Laboratories Inc. 13.1.5.1. Overview 13.1.5.2. Product Portfolio 13.1.5.3. Profitability by Market Segments 13.1.5.4. Sales Footprint 13.1.5.5. Strategy Overview 13.1.5.5.1. Marketing Strategy 13.1.5.5.2. Product Strategy 13.1.5.5.3. Channel Strategy 13.1.6. Neogen Corporation 13.1.6.1. Overview 13.1.6.2. Product Portfolio 13.1.6.3. Profitability by Market Segments 13.1.6.4. Sales Footprint 13.1.6.5. Strategy Overview 13.1.6.5.1. Marketing Strategy 13.1.6.5.2. Product Strategy 13.1.6.5.3. Channel Strategy 13.1.7. Redwood Toxicology Laboratory 13.1.7.1. Overview 13.1.7.2. Product Portfolio 13.1.7.3. Profitability by Market Segments 13.1.7.4. Sales Footprint 13.1.7.5. Strategy Overview 13.1.7.5.1. Marketing Strategy 13.1.7.5.2. Product Strategy 13.1.7.5.3. Channel Strategy 13.1.8. Principle Laboratory 13.1.8.1. Overview 13.1.8.2. Product Portfolio 13.1.8.3. Profitability by Market Segments 13.1.8.4. Sales Footprint 13.1.8.5. Strategy Overview 13.1.8.5.1. Marketing Strategy 13.1.8.5.2. Product Strategy 13.1.8.5.3. Channel Strategy 13.1.9. Pacific Toxicology Laboratories 13.1.9.1. Overview 13.1.9.2. Product Portfolio 13.1.9.3. Profitability by Market Segments 13.1.9.4. Sales Footprint 13.1.9.5. Strategy Overview 13.1.9.5.1. Marketing Strategy 13.1.9.5.2. Product Strategy 13.1.9.5.3. Channel Strategy 13.1.10. Medical Toxicology Laboratory, LLC 13.1.10.1. Overview 13.1.10.2. Product Portfolio 13.1.10.3. Profitability by Market Segments 13.1.10.4. Sales Footprint 13.1.10.5. Strategy Overview 13.1.10.5.1. Marketing Strategy 13.1.10.5.2. Product Strategy 13.1.10.5.3. Channel Strategy 14. Assumptions & Acronyms Used 15. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: North America Industry Value (US$ Million) Forecast by Region, 2019-2034
Table 02: North America Industry Volume (Units) Forecast by Region, 2019-2034
Table 03: North America Industry Value (US$ Million) Forecast by Drug Class, 2019-2034
Table 04: North America Industry Volume (Units) Forecast by Drug Class, 2019-2034
Table 05: North America Industry Value (US$ Million) Forecast by Product, 2019-2034
Table 06: North America Industry Volume (Units) Forecast by Product, 2019-2034
Table 07: North America Industry Value (US$ Million) Forecast by Sample, 2019-2034
Table 08: North America Industry Volume (Units) Forecast by Sample, 2019-2034
Table 09: North America Industry Value (US$ Million) Forecast by End User, 2019-2034
Table 10: North America Industry Volume (Units) Forecast by End User, 2019-2034
Table 11: U.S. Industry Value (US$ Million) Forecast by Region, 2019-2034
Table 12: U.S. Industry Volume (Units) Forecast by Region, 2019-2034
Table 13: U.S. Industry Value (US$ Million) Forecast by Drug Class, 2019-2034
Table 14: U.S. Industry Volume (Units) Forecast by Drug Class, 2019-2034
Table 15: U.S. Industry Value (US$ Million) Forecast by Product, 2019-2034
Table 16: U.S. Industry Volume (Units) Forecast by Product, 2019-2034
Table 17: U.S. Industry Value (US$ Million) Forecast by Sample, 2019-2034
Table 18: U.S. Industry Volume (Units) Forecast by Sample, 2019-2034
Table 19: U.S. Industry Value (US$ Million) Forecast by End User, 2019-2034
Table 20: U.S. Industry Volume (Units) Forecast by End User, 2019-2034
Table 21: Canada Industry Value (US$ Million) Forecast by Region, 2019-2034
Table 22: Canada Industry Volume (Units) Forecast by Region, 2019-2034
Table 23: Canada Industry Value (US$ Million) Forecast by Drug Class, 2019-2034
Table 24: Canada Industry Volume (Units) Forecast by Drug Class, 2019-2034
Table 25: Canada Industry Value (US$ Million) Forecast by Product, 2019-2034
Table 26: Canada Industry Volume (Units) Forecast by Product, 2019-2034
Table 27: Canada Industry Value (US$ Million) Forecast by Sample, 2019-2034
Table 28: Canada Industry Volume (Units) Forecast by Sample, 2019-2034
Table 29: Canada Industry Value (US$ Million) Forecast by End User, 2019-2034
Table 30: Canada Industry Volume (Units) Forecast by End User, 2019-2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: North America Industry Value (US$ Million) by Drug Class, 2024-2034
Figure 02: North America Industry Value (US$ Million) by Product, 2024-2034
Figure 03: North America Industry Value (US$ Million) by Sample, 2024-2034
Figure 04: North America Industry Value (US$ Million) by End User, 2024-2034
Figure 05: North America Industry Value (US$ Million) by Country, 2024-2034
Figure 06: North America Industry Value (US$ Million) Analysis by Country, 2019-2034
Figure 07: North America Industry Volume (Units) Analysis by Country, 2019-2034
Figure 08: North America Industry Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 09: North America Industry Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 10: North America Industry Value (US$ Million) Analysis by Drug Class, 2019-2034
Figure 11: North America Industry Volume (Units) Analysis by Drug Class, 2019-2034
Figure 12: North America Industry Value Share (%) and BPS Analysis by Drug Class, 2024-2034
Figure 13: North America Industry Y-o-Y Growth (%) Projections by Drug Class, 2024-2034
Figure 14: North America Industry Value (US$ Million) Analysis by Product, 2019-2034
Figure 15: North America Industry Volume (Units) Analysis by Product, 2019-2034
Figure 16: North America Industry Value Share (%) and BPS Analysis by Product, 2024-2034
Figure 17: North America Industry Y-o-Y Growth (%) Projections by Product, 2024-2034
Figure 18: North America Industry Value (US$ Million) Analysis by Sample, 2019-2034
Figure 19: North America Industry Volume (Units) Analysis by Sample, 2019-2034
Figure 20: North America Industry Value Share (%) and BPS Analysis by Sample, 2024-2034
Figure 21: North America Industry Y-o-Y Growth (%) Projections by Sample, 2024-2034
Figure 22: North America Industry Value (US$ Million) Analysis by End User, 2019-2034
Figure 23: North America Industry Volume (Units) Analysis by End User, 2019-2034
Figure 24: North America Industry Value Share (%) and BPS Analysis by End User, 2024-2034
Figure 25: North America Industry Y-o-Y Growth (%) Projections by End User, 2024-2034
Figure 26: North America Industry Attractiveness by Drug Class, 2024-2034
Figure 27: North America Industry Attractiveness by Product, 2024-2034
Figure 28: North America Industry Attractiveness by Sample, 2024-2034
Figure 29: North America Industry Attractiveness by End User, 2024-2034
Figure 30: North America Industry Attractiveness by Country, 2024-2034
Figure 31: U.S. Industry Value (US$ Million) by Drug Class, 2024-2034
Figure 32: U.S. Industry Value (US$ Million) by Product, 2024-2034
Figure 33: U.S. Industry Value (US$ Million) by Sample, 2024-2034
Figure 34: U.S. Industry Value (US$ Million) by End User, 2024-2034
Figure 35: U.S. Industry Value (US$ Million) by Region, 2024-2034
Figure 36: U.S. Industry Value (US$ Million) Analysis by Region, 2019-2034
Figure 37: U.S. Industry Volume (Units) Analysis by Region, 2019-2034
Figure 38: U.S. Industry Value Share (%) and BPS Analysis by Region, 2024-2034
Figure 39: U.S. Industry Y-o-Y Growth (%) Projections by Region, 2024-2034
Figure 40: U.S. Industry Value (US$ Million) Analysis by Drug Class, 2019-2034
Figure 41: U.S. Industry Volume (Units) Analysis by Drug Class, 2019-2034
Figure 42: U.S. Industry Value Share (%) and BPS Analysis by Drug Class, 2024-2034
Figure 43: U.S. Industry Y-o-Y Growth (%) Projections by Drug Class, 2024-2034
Figure 44: U.S. Industry Value (US$ Million) Analysis by Product, 2019-2034
Figure 45: U.S. Industry Volume (Units) Analysis by Product, 2019-2034
Figure 46: U.S. Industry Value Share (%) and BPS Analysis by Product, 2024-2034
Figure 47: U.S. Industry Y-o-Y Growth (%) Projections by Product, 2024-2034
Figure 48: U.S. Industry Value (US$ Million) Analysis by Sample, 2019-2034
Figure 49: U.S. Industry Volume (Units) Analysis by Sample, 2019-2034
Figure 50: U.S. Industry Value Share (%) and BPS Analysis by Sample, 2024-2034
Figure 51: U.S. Industry Y-o-Y Growth (%) Projections by Sample, 2024-2034
Figure 52: U.S. Industry Value (US$ Million) Analysis by End User, 2019-2034
Figure 53: U.S. Industry Volume (Units) Analysis by End User, 2019-2034
Figure 54: U.S. Industry Value Share (%) and BPS Analysis by End User, 2024-2034
Figure 55: U.S. Industry Y-o-Y Growth (%) Projections by End User, 2024-2034
Figure 56: U.S. Industry Attractiveness by Drug Class, 2024-2034
Figure 57: U.S. Industry Attractiveness by Product, 2024-2034
Figure 58: U.S. Industry Attractiveness by Sample, 2024-2034
Figure 59: U.S. Industry Attractiveness by End User, 2024-2034
Figure 60: U.S. Industry Attractiveness by Region, 2024-2034
Figure 61: Canada Industry Value (US$ Million) by Drug Class, 2024-2034
Figure 62: Canada Industry Value (US$ Million) by Product, 2024-2034
Figure 63: Canada Industry Value (US$ Million) by Sample, 2024-2034
Figure 64: Canada Industry Value (US$ Million) by End User, 2024-2034
Figure 65: Canada Industry Value (US$ Million) by Region, 2024-2034
Figure 66: Canada Industry Value (US$ Million) Analysis by Region, 2019-2034
Figure 67: Canada Industry Volume (Units) Analysis by Region, 2019-2034
Figure 68: Canada Industry Value Share (%) and BPS Analysis by Region, 2024-2034
Figure 69: Canada Industry Y-o-Y Growth (%) Projections by Region, 2024-2034
Figure 70: Canada Industry Value (US$ Million) Analysis by Drug Class, 2019-2034
Figure 71: Canada Industry Volume (Units) Analysis by Drug Class, 2019-2034
Figure 72: Canada Industry Value Share (%) and BPS Analysis by Drug Class, 2024-2034
Figure 73: Canada Industry Y-o-Y Growth (%) Projections by Drug Class, 2024-2034
Figure 74: Canada Industry Value (US$ Million) Analysis by Product, 2019-2034
Figure 75: Canada Industry Volume (Units) Analysis by Product, 2019-2034
Figure 76: Canada Industry Value Share (%) and BPS Analysis by Product, 2024-2034
Figure 77: Canada Industry Y-o-Y Growth (%) Projections by Product, 2024-2034
Figure 78: Canada Industry Value (US$ Million) Analysis by Sample, 2019-2034
Figure 79: Canada Industry Volume (Units) Analysis by Sample, 2019-2034
Figure 80: Canada Industry Value Share (%) and BPS Analysis by Sample, 2024-2034
Figure 81: Canada Industry Y-o-Y Growth (%) Projections by Sample, 2024-2034
Figure 82: Canada Industry Value (US$ Million) Analysis by End User, 2019-2034
Figure 83: Canada Industry Volume (Units) Analysis by End User, 2019-2034
Figure 84: Canada Industry Value Share (%) and BPS Analysis by End User, 2024-2034
Figure 85: Canada Industry Y-o-Y Growth (%) Projections by End User, 2024-2034
Figure 86: Canada Industry Attractiveness by Drug Class, 2024-2034
Figure 87: Canada Industry Attractiveness by Product, 2024-2034
Figure 88: Canada Industry Attractiveness by Sample, 2024-2034
Figure 89: Canada Industry Attractiveness by End User, 2024-2034
Figure 90: Canada Industry Attractiveness by Region, 2024-2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Toxicology Laboratory Industry Analysis in North America